Despite excellent results applying PSMA-RADS 1.0 without clinical knowledge, PSA represents an important biomarker for prostate cancer and by the lack of PSA-values in the framework, important information on risk stratification of patients may be missing. Here, KLK3 is linked to prostate cancer.